Sign in   |   Register
HOME MARKET NEWS CENTRE ECONOMY RESEARCH MUTUAL FUNDS FINANCIAL PLANNING INSURANCE BUDGET ABOUT US F&O IPO Commodities Stock-Screener Get NAV Snapshot Portfolio Dividends News Interviews Charts 04 July, 2025 09:02 IST Get Quote Snapshot Charts Financials Research News iWealth Tracker Newsletter Tax Corner Financial Health Check Expert Speak Feedback Follow @myirisdotcom

Biocon partners with Tabuk Pharmaceuticals Source: IRIS | 07 Dec, 2021, 01.38PM Rating: NAN / 5 stars. Comments  |  Post Comment Notice: Undefined variable: fileR in /me/beta.myiris.com/htdocs/newsCentre/bin/addLinksNew.php on line 17 Notice: Undefined variable: fileR in /me/beta.myiris.com/htdocs/newsCentre/bin/addLinksNew.php on line 142 Biocon, a leading biotechnology company, on December 07, announced a partnership with Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a leading pharmaceutical company in the Middle East and North Africa (MENA), to commercialise select speciality products in the Middle East. Under the terms of this agreement, Tabuk Pharmaceuticals will hold the marketing authorization for these products and will be responsible to register, import, and promote them in Saudi Arabia and other Middle East countries. The partnership will pave the way for Biocon’s expansion into the MENA region to include Saudi Arabia, UAE, Kuwait, Qatar, Oman and Iraq, in addition to Jordan and Lebanon. This is another important milestone for Biocon, reflecting its commitment to providing patients around the globe with affordable medications, by establishing a strong global portfolio of products, either directly, or through strategic partnerships. As part of the out-licensing deal with Tabuk, Biocon will develop and manufacture the products, and Tabuk will commercialise them. Siddharth Mittal, Chief Executive Officer and Managing Director, Biocon said, "Our partnership with Tabuk Pharmaceuticals is another significant step as we continue to expand our global presence with our portfolio of high quality, vertically-integrated generic formulations, to address unmet medical needs. We are extremely pleased to collaborate with Tabuk, whose deep expertise will help us build a solid foundation in key Middle East markets." Shares of the company gained Rs 4.80, or 1.34%, to trade at Rs 364.05.  The total volume of shares traded was 30, 650 at the BSE (12.12 p.m, Tuesday).  Post Comment Name Email Comment Security Code type    Notice: Undefined variable: captchacode in /me/beta.myiris.com/htdocs/newsCentre/comments.php on line 183 into this box

Related Articles

Notice: Constant DOC_ROOT_FOR_HTML_FILES already defined in /me/beta.myiris.com/htdocs/newsCentre/rightSideTabs.php on line 1 Most Read Expert Speak 22-09-16 Sensex surges over 300 points as US Federal Reserve holds rate 22-09-16 Sensex gains 281 points; Nifty trades at 8,862-level 22-09-16 Rupee appreciates 18 paise against dollar in early trade 22-09-16 Edelweiss Group to acquire Ambit Alpha Fund more... more...

Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise © All rights reserved. IRIS Business Services Limited A Disclaimer

Warning: fopen(/me/beta.myiris.com/htdocs/newsCentre/news_web_count.txt): failed to open stream: Permission denied in /me/beta.myiris.com/htdocs/newsCentre/storyShow.php on line 566

Warning: fwrite() expects parameter 1 to be resource, boolean given in /me/beta.myiris.com/htdocs/newsCentre/storyShow.php on line 567

Warning: fclose() expects parameter 1 to be resource, boolean given in /me/beta.myiris.com/htdocs/newsCentre/storyShow.php on line 568

Notice: Undefined index: key in /me/beta.myiris.com/htdocs/newsCentre/storyShow.php on line 571